🇧🇷 dapagliflozin and saxagliptin in Brazil

dapagliflozin and saxagliptin (dapagliflozin and saxagliptin) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

dapagliflozin and saxagliptin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dapagliflozin and saxagliptin approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for dapagliflozin and saxagliptin in Brazil?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.